Cirrhosis with ascites: Is the presence of hemorrhagic ascites an indicator of poor prognosis?

Hakan Yıldız, Meral Akdoğan, Nuretdin Suna, Erkin Öztaş, Ufuk B Kuzu, Zülfükar Bilge, Onur Aydınlı, İsmail Taşkıran
{"title":"Cirrhosis with ascites: Is the presence of hemorrhagic ascites an indicator of poor prognosis?","authors":"Hakan Yıldız,&nbsp;Meral Akdoğan,&nbsp;Nuretdin Suna,&nbsp;Erkin Öztaş,&nbsp;Ufuk B Kuzu,&nbsp;Zülfükar Bilge,&nbsp;Onur Aydınlı,&nbsp;İsmail Taşkıran","doi":"10.5152/tjg.2016.160042","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aims: </strong>Hemorrhagic ascites in patients with cirrhosis is described as a RBC (Red Blood cell) > 50,000/mm³ and leads to increased morbidity and mortality. Positive red blood cells at a level of less than 50,000/mm³ (10,000-50,000) may be encountered in the ascites but it is not known whether this is clinically significant or not. This study aimed to examine the outcome of hemorrhagic ascites in patients with advanced cirrhosis.</p><p><strong>Materials and methods: </strong>Data from 329 cirrhotic patients with ascites who received paracentesis at least once due to ascites was retrospectively analyzed from the period of 2007-2013 from the Türkiye Yüksek İhtisas Hospital, Department of Gastroenterology. Patients were divided according to the number of RBC, with greater than 10,000/mm³ being described as hemorrhagic ascites, and less than 10,000/mm³ described as the normal or control group. Patient data included: number of accepted intensive unit service stays, acute kidney injury (AKI), hepatic encephalopathy (HES), model for end-liver disease (MELD) score, Child Pugh score (CPS), degree of esophageal varices, spleen size and mortality rates.</p><p><strong>Results: </strong>Patients were defined as having hemorrhagic ascites with a RBC count greater than 10,000/mm³ in 118 (35.9%) patients and as a non-hemorrhagic ascites group with less than 10,000/mm³ in 211 (64.1%) patients. The hemorrhagic ascites group had advanced liver disease symptoms compared to the control group. Meld score in the hemorrhagic group was statistically higher than in the control group (21.5±8.3 vs. 17.3±6.6; p value: 0.001). The median value of bilirubin was 5.9 (0.45-33) in the hemorrhagic ascites group and 4.01 (0.39-33) in the non-hemorrhagic group (p value: 0.001). Using multivariate logistic regression analysis, hemorrhagic ascites was also an independent predictor of mortality (HR 2.7 1.4-6.3), with other mortality indicators being HCC (HR 3.1 1.5-6.4) and HRS (HR 2.6 1.2-5.5).</p><p><strong>Conclusion: </strong>Patients with hemorrhagic ascites had higher HRS, SBP and admissions to the intensive care unit. We believe that the presence of hemorrhagic ascites can be used as a marker for advanced liver disease and for predicting mortality.</p>","PeriodicalId":518528,"journal":{"name":"The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology","volume":" ","pages":"349-53"},"PeriodicalIF":0.0000,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5152/tjg.2016.160042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/4/28 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Background/aims: Hemorrhagic ascites in patients with cirrhosis is described as a RBC (Red Blood cell) > 50,000/mm³ and leads to increased morbidity and mortality. Positive red blood cells at a level of less than 50,000/mm³ (10,000-50,000) may be encountered in the ascites but it is not known whether this is clinically significant or not. This study aimed to examine the outcome of hemorrhagic ascites in patients with advanced cirrhosis.

Materials and methods: Data from 329 cirrhotic patients with ascites who received paracentesis at least once due to ascites was retrospectively analyzed from the period of 2007-2013 from the Türkiye Yüksek İhtisas Hospital, Department of Gastroenterology. Patients were divided according to the number of RBC, with greater than 10,000/mm³ being described as hemorrhagic ascites, and less than 10,000/mm³ described as the normal or control group. Patient data included: number of accepted intensive unit service stays, acute kidney injury (AKI), hepatic encephalopathy (HES), model for end-liver disease (MELD) score, Child Pugh score (CPS), degree of esophageal varices, spleen size and mortality rates.

Results: Patients were defined as having hemorrhagic ascites with a RBC count greater than 10,000/mm³ in 118 (35.9%) patients and as a non-hemorrhagic ascites group with less than 10,000/mm³ in 211 (64.1%) patients. The hemorrhagic ascites group had advanced liver disease symptoms compared to the control group. Meld score in the hemorrhagic group was statistically higher than in the control group (21.5±8.3 vs. 17.3±6.6; p value: 0.001). The median value of bilirubin was 5.9 (0.45-33) in the hemorrhagic ascites group and 4.01 (0.39-33) in the non-hemorrhagic group (p value: 0.001). Using multivariate logistic regression analysis, hemorrhagic ascites was also an independent predictor of mortality (HR 2.7 1.4-6.3), with other mortality indicators being HCC (HR 3.1 1.5-6.4) and HRS (HR 2.6 1.2-5.5).

Conclusion: Patients with hemorrhagic ascites had higher HRS, SBP and admissions to the intensive care unit. We believe that the presence of hemorrhagic ascites can be used as a marker for advanced liver disease and for predicting mortality.

肝硬化伴腹水:出血性腹水是预后不良的指标吗?
背景/目的:肝硬化患者出血性腹水被描述为RBC(红细胞)> 50,000/mm³,并导致发病率和死亡率增加。在腹水中可能会遇到低于50,000/mm³(10,000-50,000)的阳性红细胞,但尚不清楚这是否具有临床意义。本研究旨在探讨晚期肝硬化患者出血性腹水的预后。材料和方法:回顾性分析来自 rkiye yksek İhtisas医院消化内科2007-2013年期间329例因腹水接受过至少一次穿刺的肝硬化腹水患者的数据。根据红细胞数量进行分组,大于10000 /mm³为出血性腹水,小于10000 /mm³为正常或对照组。患者资料包括:接受重症监护病房服务时间、急性肾损伤(AKI)、肝性脑病(HES)、终末肝病模型(MELD)评分、Child Pugh评分(CPS)、食管静脉曲张程度、脾脏大小和死亡率。结果:118例(35.9%)患者定义为出血性腹水,RBC计数大于10,000/mm³;211例(64.1%)患者定义为非出血性腹水组,RBC计数小于10,000/mm³。与对照组相比,出血性腹水组有晚期肝脏疾病症状。出血性组Meld评分显著高于对照组(21.5±8.3∶17.3±6.6;P值:0.001)。出血性腹水组胆红素中位值为5.9(0.45-33),非出血性腹水组胆红素中位值为4.01 (0.39-33)(p值:0.001)。通过多因素logistic回归分析,出血性腹水也是死亡率的独立预测因子(HR 2.7 1.4-6.3),其他死亡率指标为HCC (HR 3.1 1.5-6.4)和HRS (HR 2.6 1.2-5.5)。结论:出血性腹水患者有较高的HRS、收缩压和入住重症监护病房的风险。我们认为出血性腹水的存在可以作为晚期肝病的标志和预测死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信